LeMaitre to Present at Upcoming Investor Conferences
Rhea-AI Summary
LeMaitre Vascular, Inc. (Nasdaq:LMAT) will participate in two investor conferences in May and June 2022. CFO JJ Pellegrino is set to present at the UBS Global Healthcare Conference on May 23 at 2:00 PM ET in New York City. Additionally, President David Roberts will present at the Jefferies Healthcare Conference on June 8 at 9:30 AM ET, also in New York City. LeMaitre is a key provider of devices and services for treating peripheral vascular disease, affecting over 200 million people globally.
Positive
- None.
Negative
- None.
News Market Reaction – LMAT
In the trading session that priced this news, LMAT gained 4.43%, reflecting a moderate positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
BURLINGTON, Mass., May 16, 2022 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it is participating in two upcoming investor conferences.
JJ Pellegrino, Chief Financial Officer, will present at the UBS Global Healthcare Conference on Monday, May 23, 2022 at the Lotte New York Palace in New York City. The company’s presentation is scheduled at 2:00 PM ET.
David Roberts, President, will present at the Jefferies in the Jefferies Healthcare Conference on Wednesday, June 8, 2022 at the Marriott Marquis in New York City. The company’s presentation is scheduled at 9:30 AM ET.
About LeMaitre
LeMaitre is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Additional information can be found at www.lemaitre.com.
